【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top investment pockets
2.2.2. Top impacting factors
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key forces shaping companion diagnostics industry/market
3.2.1. Moderate power of suppliers
3.2.2. High threat of new entrants
3.2.3. Low threat of substitution
3.2.4. Moderate competitive rivalry
3.2.5. Moderate power of buyers
3.3. Parent/ peer market overview
3.5. Market evolution/industry roadmap
3.6. Government regulations for companion diagnostics
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Increased popularity of personalized medicine
3.7.1.2. Increase in cases of adverse drug reactions (ADRs)
3.7.1.3. Surge in healthcare expenditure worldwide
3.7.1.4. Technological advancements in diagnostic techniques
3.7.2. Restraints
3.7.2.1. Unfavorable reimbursement policies in some countries
3.7.3. Opportunities
3.7.3.1. Growth opportunities in emerging markets
3.7.3.2. Increase in incidence of cancer across the globe
3.7.4. Impact analysis
CHAPTER 4: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Immunohistochemistry
4.2.1. Market size and forecast, by region
4.2.2. Market analysis, by country
4.3. Polymerase chain reaction (PCR)
4.3.1. Market size and forecast, by region
4.3.2. Market analysis, by country
4.4. Next generation sequencing (NGS)
4.4.1. Market size and forecast, by region
4.4.2. Market analysis, by country
4.5. In situ hybridization
4.5.1. Market size and forecast, by region
4.5.2. Market analysis, by country
4.6. Others
4.6.1. Market size and forecast, by region
4.6.2. Market analysis, by country
CHAPTER 5: COMPANION DIAGNOSTICS MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oncology
5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast, by type
5.2.2.1. Lung cancer
5.2.2.1.1. Market size and forecast
5.2.2.2. Colorectal cancer
5.2.2.2.1. Market size and forecast
5.2.2.3. Breast cancer
5.2.2.3.1. Market size and forecast
5.2.2.4. Blood cancer
5.2.2.4.1. Market size and forecast
5.2.2.5. Others
5.2.2.5.1. Market size and forecast
5.2.3. Market size and forecast
5.2.4. Market analysis, by country
5.3. Neurology
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
CHAPTER 6: COMPANION DIAGNOSTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. companion diagnostics market, by technology
6.2.2.1.2. U.S. companion diagnostics market, by indication
6.2.2.2. Canada
6.2.2.2.1. Canada companion diagnostics market, by technology
6.2.2.2.2. Canada companion diagnostics market, by indication
6.2.2.3. Mexico
6.2.2.3.1. Mexico companion diagnostics market, by technology
6.2.2.3.2. Mexico companion diagnostics market, by indication
6.2.3. North America market size and forecast, by technology
6.2.4. North America Market size and forecast, by indication
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany companion diagnostics market, by technology
6.3.2.1.2. Germany companion diagnostics market, by indication
6.3.2.2. France
6.3.2.2.1. France companion diagnostics market, by technology
6.3.2.2.2. France companion diagnostics market, by indication
6.3.2.3. UK
6.3.2.3.1. UK companion diagnostics market, by technology
6.3.2.3.2. UK companion diagnostics market, by indication
6.3.2.4. Rest of Europe
6.3.2.4.1. Rest of Europe companion diagnostics market, by technology
6.3.2.4.2. Rest of Europe companion diagnostics market, by indication
6.3.3. Europe market size and forecast, by technology
6.3.4. Europe Market size and forecast, by indication
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan companion diagnostics market, by technology
6.4.2.1.2. Japan companion diagnostics market, by indication
6.4.2.2. China
6.4.2.2.1. China companion diagnostics market, by technology
6.4.2.2.2. China companion diagnostics market, by indication
6.4.2.3. Australia
6.4.2.3.1. Australia companion diagnostics market, by technology
6.4.2.3.2. Australia companion diagnostics market, by indication
6.4.2.4. Rest of Asia-Pacific
6.4.2.4.1. Rest of Asia-Pacific companion diagnostics market, by technology
6.4.2.4.2. Rest of Asia-Pacific companion diagnostics market, by indication
6.4.3. Asia-Pacific market size and forecast, by technology
6.4.4. Asia-Pacific Market size and forecast, by indication
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil companion diagnostics market, by technology
6.5.2.1.2. Brazil companion diagnostics market, by indication
6.5.2.2. South Africa
6.5.2.2.1. South Africa companion diagnostics market, by technology
6.5.2.2.2. South Africa companion diagnostics market, by indication
6.5.2.3. Rest of LAMEA
6.5.2.3.1. Rest of LAMEA companion diagnostics market, by technology
6.5.2.3.2. Rest of LAMEA companion diagnostics market, by indication
6.5.3. LAMEA market size and forecast, by technology
6.5.4. LAMEA Market size and forecast, by indication
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.1.1. Market player positioning, 2018
7.2. Top winning strategies
7.3. Competitive dashboard
7.4. Competitive heatmap
CHAPTER 8: COMPANY PROFILES
8.1. Abbott Laboratories Molecular, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Agilent (Dako Denmark A/S)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. ARUP Laboratories, Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Service portfolio
8.4. BioMerieux
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Danaher Corporation (Leica Microsystems)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. Foundation Medicine, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Service portfolio
8.6.5. Key strategic moves and developments
8.7. Myriad Genetics, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Roche (Ventana Medical Systems, Inc)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Thermo Fisher Scientific (Life Technologies Corporation)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. QIAGEN N.V.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
【レポート販売概要】
■ タイトル：コンパニオン診断の世界市場：免疫組織化学、ポリメラーゼ連鎖反応[PCR]、次世代シーケンシング[NGS]、in situハイブリダイゼーション■ 英文：Companion Diagnostics Market by Technology Type (Immunohistochemistry, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], In Situ Hybridization, and Others), and Indication (Oncology, Neurology, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年7月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9NV073
■ 調査対象地域：グローバル
- 世界の酸化ジルコニウム市場2015Global Zirconium Oxide Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Zirconium Oxide industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Zirconium Oxide market analysis is provided for the international markets including development trends, compe …
- 蕁麻疹治療薬の世界市場2018-2022About this market Urticaria is a vastly prevalent disorder resulting in high medical consultations globally. The increase in risk factors for urticaria like latent infectious, chronic inflammatory diseases, autoreactivity and alcohol consumption. Though the incident is increasing, and it is negatively impacting the quality of life of the people, most patients are undertreated due to challenges in …
- クラフトビールのグローバル市場：経営者意識調査（消費者の期待と企業の戦略）Summary “Global Executives Survey: Craft Products - Consumer Expectations and Organizations Strategic Approach” is a new report by Canadean that analyzes key attributes associated with craft products, opinion about capability of major brands/ multinational businesses to launch “craft” products. The report also examines executive opinion about the projected change in number of craft product launche …
- 世界の縫合線市場：医療機器パイプライン分析2016Sutures - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Sutures - Medical Devices Pipeline Assessment, 2016" provides an overview of Sutures currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players i …
- Regal Petroleum plc：石油・ガスの開発・生産動向及びコスト分析- 2012Regal Petroleum plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Regal Petroleum plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- エンジニアリングサービスアウトソーシング（ESO）の世界市場ESO refers to the outsourcing of specific engineering services. Engineering services are considered as a critical part of different verticals. Technavios market research analysts expect the global engineering services outsourcing (ESO) to grow at a CAGR of close to 27% until 2019. Due to the lack of expertise and increasing pressure to reduce costs, companies have started outsourcing their enginee …
- バラスト水処理の世界市場予測（～2022年）：物理的消毒法、機械的方法、化学的方法The ballast water treatment (BWT) market was valued at USD 14.29 Billion in 2016 and is expected to reach USD 118.77 Billion by 2022, at a CAGR of 37.19% during the forecast period. The growth of this market is propelled by the increasing government rules and regulations for the installation of BWT systems in the ships. The report covers the BWT market on the basis of technology, capacity, service …
- 2012年テレコム市場：トレンド、ビジネスイシュー、技術、アプリケーション（Top Telecom 2012: Trends, Business Issues, Technologies, and Applications）The telecommunications market represents a large ecosystem with multiple players, solutions, applications, technologies and relationships in a multi-billion dollar industry. It is often daunting to understand the technical and market dynamics and plan business accordingly. This report provides the reader with an understanding of leading trends, issues, challenges, and opportunities with telecommun …
- 世界のE1/T1トランシーバー(LIU/Framer)市場2015The Global E1/T1 Transceivers (LIU/Framer) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the E1/T1 Transceivers (LIU/Framer) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The E1/T1 Transceivers (LIU/Framer) market analysis is provided for the intern …
- 風力タービン検査用ドローンの世界市場ABSTRACTAbout Wind Turbine Inspection Drones Wind turbine inspection drones are unmanned aerial vehicles catering to the civilian segment of end-users. They are used to gather information and images of wind turbine blades, nacelles, and towers. They are implemented along with inspection services and software that are used to facilitate the monitoring, mapping, and analysis across various sectors, …
- 生検用機器の世界市場2016-2020About Biopsy A biopsy is a medical procedure through which a part or full tissue is removed from an organ to examine the presence or extent of a disease. Biopsies are mostly performed in in the critical areas of the body such as the liver, lungs, prostate, and kidney using a wide range of devices. Technavio’s analysts forecast the global biopsy devices market to grow at a CAGR of: 6.41% during the …
- 動物用ワクチンの世界市場予測（～2022年）：種類、疾患、技術別分析“Veterinary Vaccines market is projected to register a CAGR of 5.9%”The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of 5.9% during the forecast period. Market growth can be attributed to factors such as growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; …
- 動物用抗菌薬及び抗生物質のグローバル市場動向（～2018）Antimicrobials and antibiotics form a major share of the animal health market. Animal antimicrobials gained a greater importance in the animal health industry in the past 20 years, mainly due to growing need to preserve the health and welfare of animals. Most of the antimicrobial agents were also used as growth promoters as well. With this, the animal antimicrobials market witnessed a bullish grow …
- 世界の次世代通信アプリケーションサーバー市場動向（2012-2016）TechNavio's analysts forecast the Global Next-Generation Telecom Application Server market to grow at a CAGR of 15.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for multimedia services. The Global Next-Generation Telecom Application Server market has also been witnessing increasing demand for IP-based services. However, the …
- Stivarga：大腸癌治療薬市場分析Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on …
